Captrust Financial Advisors Sells 9,911 Shares of HCA Healthcare, Inc. $HCA

Captrust Financial Advisors cut its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 3.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 295,794 shares of the company’s stock after selling 9,911 shares during the period. Captrust Financial Advisors’ holdings in HCA Healthcare were worth $138,094,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Nordea Investment Management AB increased its holdings in HCA Healthcare by 11.2% during the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after purchasing an additional 108,849 shares in the last quarter. Hudson Bay Capital Management LP boosted its stake in shares of HCA Healthcare by 154.5% in the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock worth $2,000,000 after buying an additional 2,849 shares during the last quarter. Nomura Asset Management Co. Ltd. boosted its stake in shares of HCA Healthcare by 6.2% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after buying an additional 3,724 shares during the last quarter. Advisors Capital Management LLC boosted its stake in shares of HCA Healthcare by 61.5% in the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after buying an additional 2,604 shares during the last quarter. Finally, CWA Asset Management Group LLC boosted its stake in shares of HCA Healthcare by 1,062.4% in the 4th quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock worth $4,461,000 after buying an additional 8,733 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Up 1.7%

Shares of NYSE:HCA opened at $396.55 on Wednesday. The stock’s 50-day moving average price is $426.45 and its 200-day moving average price is $471.57. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The stock has a market capitalization of $87.97 billion, a P/E ratio of 13.64, a price-to-earnings-growth ratio of 1.24 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same period last year, the business posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on HCA shares. Mizuho boosted their target price on HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 25th. Robert W. Baird reduced their target price on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Argus reduced their target price on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Stephens reduced their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Fifteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.